TY - JOUR
T1 - Prevalence and characteristics of sleep-disordered breathing in familial dysautonomia
AU - Singh, Kanwaljit
AU - Palma, Jose Alberto
AU - Kaufmann, Horacio
AU - Tkachenko, Nataliya
AU - Norcliffe-Kaufmann, Lucy
AU - Spalink, Christy
AU - Kazachkov, Mikhail
AU - Kothare, Sanjeev V.
N1 - Publisher Copyright:
© 2018 Elsevier B.V.
PY - 2018/5
Y1 - 2018/5
N2 - Objective: Familial dysautonomia (FD) is an autosomal recessive disorder characterized by impaired development of sensory and afferent autonomic nerves. Untreated sleep-disordered breathing (SDB) has been reported to increase the risk of sudden unexpected death in FD. We aimed to describe the prevalence and characteristics of SDB in FD. Patients/Methods: Seventy-five patients with FD (20 adults and 55 children) underwent in-lab polysomnography, including peripheral capillary oxygen saturation (SpO 2 ) and end-tidal capnography (EtCO 2 ) measurements. A t-test and Spearman's correlation analysis were performed to evaluate the impact of age on sleep, occurrence of apneas, SpO 2 and EtCO 2 levels; and to determine the relationship between apneas and SpO 2 /EtCO 2 measurements during different sleep stages. Results: Overall, 85% of adults and 91% of pediatric patients had some degree of SDB. Obstructive sleep apneas were more severe in adults (8.5 events/h in adults vs. 3.5 events/h in children, p = 0.04), whereas central apneas were more severe (10.8 vs. 2.8 events/h, p = 0.04) and frequent (61.8% vs. 45%, p = 0.017) in children. Overall, a higher apnea–hypopnea index was associated with increased severity of hypoxia and hypoventilation, although in a significant fraction of patients (67% and 46%), hypoxemia and hypoventilation occurred independent of apneas. Conclusion: Most adult and pediatric patients with FD suffer from some degree of SDB. There was a differential effect of age in the pattern of SDB observed. In some FD patients, hypoventilation and hypoxia occurred independently of apneas. Therefore, we recommend including EtCO 2 monitoring during polysomnography in all patients with FD to detect SDB.
AB - Objective: Familial dysautonomia (FD) is an autosomal recessive disorder characterized by impaired development of sensory and afferent autonomic nerves. Untreated sleep-disordered breathing (SDB) has been reported to increase the risk of sudden unexpected death in FD. We aimed to describe the prevalence and characteristics of SDB in FD. Patients/Methods: Seventy-five patients with FD (20 adults and 55 children) underwent in-lab polysomnography, including peripheral capillary oxygen saturation (SpO 2 ) and end-tidal capnography (EtCO 2 ) measurements. A t-test and Spearman's correlation analysis were performed to evaluate the impact of age on sleep, occurrence of apneas, SpO 2 and EtCO 2 levels; and to determine the relationship between apneas and SpO 2 /EtCO 2 measurements during different sleep stages. Results: Overall, 85% of adults and 91% of pediatric patients had some degree of SDB. Obstructive sleep apneas were more severe in adults (8.5 events/h in adults vs. 3.5 events/h in children, p = 0.04), whereas central apneas were more severe (10.8 vs. 2.8 events/h, p = 0.04) and frequent (61.8% vs. 45%, p = 0.017) in children. Overall, a higher apnea–hypopnea index was associated with increased severity of hypoxia and hypoventilation, although in a significant fraction of patients (67% and 46%), hypoxemia and hypoventilation occurred independent of apneas. Conclusion: Most adult and pediatric patients with FD suffer from some degree of SDB. There was a differential effect of age in the pattern of SDB observed. In some FD patients, hypoventilation and hypoxia occurred independently of apneas. Therefore, we recommend including EtCO 2 monitoring during polysomnography in all patients with FD to detect SDB.
KW - EtCO
KW - Familial dysautonomia
KW - Polysomnography
KW - Sleep-disordered breathing
KW - SpO
UR - http://www.scopus.com/inward/record.url?scp=85042863334&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042863334&partnerID=8YFLogxK
U2 - 10.1016/j.sleep.2017.12.013
DO - 10.1016/j.sleep.2017.12.013
M3 - Article
C2 - 29680425
AN - SCOPUS:85042863334
SN - 1389-9457
VL - 45
SP - 33
EP - 38
JO - Sleep Medicine
JF - Sleep Medicine
ER -